Zhe Jiang Dayang Biotech Group Co., Ltd. (SHE:003017)

SHE:003017 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Net Income	101.38	99.85	63.75	50.01	80.73	70.01
Depreciation & Amortization	72.16	72.16	68.68	69.67	60.25	45.1
Other Amortization	0.67	0.67	0.24	0.05	0.05	0.05
Loss (Gain) From Sale of Assets	-2.05	-2.05	-0.09	0.17	-3.41	-0.12
Asset Writedown & Restructuring Costs	18.81	18.81	7.98	17.02	0.19	1.89
Loss (Gain) From Sale of Investments	-1.33	-1.33	-2.2	-3.21	-4.62	-11.28
Provision & Write-off of Bad Debts	1.45	1.45	1.08	-1.58	1.77	0.18
Other Operating Activities	-41.02	6.31	9.6	9.17	6.49	3.95
Change in Accounts Receivable	-128.73	-128.73	-94.51	5.99	-65.96	-40.69
Change in Inventory	9.88	9.88	30.2	-28.27	34.56	-93.26
Change in Accounts Payable	68.79	68.79	-30.75	59.87	-6.8	-16.73
Change in Other Net Operating Assets	13.05	13.05	4.46	7.27	11.95	-
Operating Cash Flow	114.3	160.11	66.19	182.42	91.89	-35.16
Operating Cash Flow Growth	5.22%	141.87%	-63.71%	98.53%	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Capital Expenditures	-102.95	-76.38	-63.45	-103.63	-104.65	-93.43
Sale of Property, Plant & Equipment	4	3.93	0.94	1.36	6.85	0.72
Investment in Securities	30.64	40.64	-106	241.9	-20.48	89.35
Other Investing Activities	2.42	2.91	1.2	5.45	8.4	12.25
Investing Cash Flow	-65.88	-28.9	-167.3	145.08	-109.88	8.89

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Short-Term Debt Issued	-	593.07	-	-	-	-
Long-Term Debt Issued	-	20	715.86	519.38	556.51	138.66
Total Debt Issued	758.07	613.07	715.86	519.38	556.51	138.66
Long-Term Debt Repaid	-	-616.1	-599.44	-552.45	-454.84	-10.96
Total Debt Repaid	-665.07	-616.1	-599.44	-552.45	-454.84	-10.96
Net Debt Issued (Repaid)	93	-3.03	116.42	-33.07	101.67	127.7
Issuance of Common Stock	12.27	12.27	35.85	-	42.36	-
Repurchase of Common Stock	-3.98	-3.98	-41.96	-	-88.1	-
Common Dividends Paid	-54.45	-54.66	-42.71	-42.61	-39.06	-38.31
Dividends Paid	-54.45	-54.66	-42.71	-42.61	-39.06	-38.31
Other Financing Activities	8.63	6.59	-1.04	-	-	-
Financing Cash Flow	55.46	-42.81	66.56	-75.68	16.87	89.4

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Foreign Exchange Rate Adjustments	-1.63	-0.23	0.27	-0.1	-0.96	-0
Net Cash Flow	102.25	88.16	-34.28	251.73	-2.09	63.13

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Free Cash Flow	11.35	83.72	2.74	78.8	-12.76	-128.59
Free Cash Flow Growth	-79.86%	2950.92%	-96.52%	-	-	-
Free Cash Flow Margin	1.06%	8.01%	0.30%	8.57%	-1.21%	-16.42%
Free Cash Flow Per Share	0.12	0.85	0.03	0.81	-0.13	-1.28
Levered Free Cash Flow	94.01	148.55	-18.48	71.45	44.17	-103.2
Unlevered Free Cash Flow	96.57	151.23	-14.25	75.29	47.59	-101.47

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash Income Tax Paid	32.89	31.89	24.47	31.05	0.12	11.65
Change in Working Capital	-35.77	-35.77	-82.85	41.12	-49.56	-144.93

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error